{"id":"adhd-medication","safety":{"commonSideEffects":[{"rate":null,"effect":"Insomnia or sleep disturbance"},{"rate":null,"effect":"Decreased appetite"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Anxiety"},{"rate":null,"effect":"Elevated heart rate or blood pressure"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Most marketed ADHD medications are either stimulants (amphetamines or methylphenidate) that increase dopamine and norepinephrine release, or non-stimulants (atomoxetine, guanfacine, clonidine) that modulate these neurotransmitter systems. These mechanisms enhance prefrontal cortex function, improving executive function, focus, and behavioral regulation in patients with ADHD.","oneSentence":"ADHD medications typically work by increasing the availability of neurotransmitters like dopamine and norepinephrine in the brain to improve attention and impulse control.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:19:08.229Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention-Deficit/Hyperactivity Disorder (ADHD)"}]},"trialDetails":[{"nctId":"NCT05842330","phase":"PHASE3","title":"Benefits of ADHD Treatment in Detained People","status":"RECRUITING","sponsor":"Stéphanie Baggio","startDate":"2024-01-01","conditions":"ADHD","enrollment":150},{"nctId":"NCT06871488","phase":"PHASE4","title":"Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-03-05","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity, Irritability, Aggression Childhood","enrollment":136},{"nctId":"NCT06853665","phase":"PHASE4","title":"The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine","status":"RECRUITING","sponsor":"Gagan Joshi","startDate":"2026-02-01","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Autism, Autism Spectrum Disorder","enrollment":196},{"nctId":"NCT07001293","phase":"NA","title":"Expectant Moms Managing Attention-Deficit/ Hyperactivity Disorder","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-04","conditions":"ADHD, Perinatal, Behavioral Intervention","enrollment":80},{"nctId":"NCT03434509","phase":"NA","title":"Ongoing Tai Chi Training for Children With ADHD","status":"COMPLETED","sponsor":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","startDate":"2017-11-02","conditions":"ADHD","enrollment":15},{"nctId":"NCT05200936","phase":"PHASE2","title":"Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial","status":"COMPLETED","sponsor":"Definium Therapeutics US, Inc.","startDate":"2021-12-17","conditions":"ADHD, Attention Deficit Disorder","enrollment":53},{"nctId":"NCT05835362","phase":"NA","title":"Improving the Outcomes of Adolescents With ADHD Via a Pre-visit Question Prompt List/Video Intervention","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-03-22","conditions":"ADHD","enrollment":126},{"nctId":"NCT01075672","phase":"NA","title":"Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2010-01","conditions":"Obsessive Compulsive Disorder, Body Dysmorphic Disorder, Tourette Syndrome","enrollment":250},{"nctId":"NCT07417878","phase":"NA","title":"Study of the Nutritional, Inflammatory, and Metabolic Endophenotypes of Attention-Deficit/Hyperactivity Disorder (ADHD)","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-03","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity","enrollment":80},{"nctId":"NCT04723719","phase":"NA","title":"Sleep IntervEntion as Symptom Treatment for ADHD","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-01-28","conditions":"ADHD, Sleep, Adolescents","enrollment":92},{"nctId":"NCT06573970","phase":"PHASE4","title":"Atomoxetine and Executive Function in PTSD","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Posttraumatic Stress Disorder With Attention Defic","enrollment":160},{"nctId":"NCT04946253","phase":"NA","title":"SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2021-11-28","conditions":"Child Behavior Problem, Attention Deficit and Disruptive Behavior Disorders","enrollment":450},{"nctId":"NCT07380412","phase":"NA","title":"A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications","status":"RECRUITING","sponsor":"Outliers, Inc.","startDate":"2025-08-12","conditions":"ADHD, Sleep Disturbance, Brain Fog","enrollment":90},{"nctId":"NCT06456372","phase":"NA","title":"Digital Health Intervention for Children With ADHD","status":"RECRUITING","sponsor":"University of California, Riverside","startDate":"2025-02-22","conditions":"ADHD","enrollment":60},{"nctId":"NCT05286762","phase":"PHASE3","title":"Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301","status":"COMPLETED","sponsor":"Cingulate Therapeutics","startDate":"2023-08-01","conditions":"ADHD, Attention Deficit Hyperactivity Disorder, ADHD - Combined Type","enrollment":103},{"nctId":"NCT05592119","phase":"","title":"Effect of Stimulant Medication on Loss of Control Eating in Youth With Attention Deficit/Hyperactivity Disorder","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2023-01-11","conditions":"Loss of Control Eating, Attention Deficit/Hyperactivity Disorder","enrollment":10},{"nctId":"NCT05776056","phase":"PHASE4","title":"Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-02-05","conditions":"Posttraumatic Stress Disorder (PTSD)","enrollment":70},{"nctId":"NCT07300956","phase":"PHASE4","title":"Treating Young Children With Attention Deficit Hyperactivity Disorder","status":"NOT_YET_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2026-02","conditions":"Attention-Deficit/Hyperactivity Disorder (ADHD)","enrollment":370},{"nctId":"NCT06860763","phase":"NA","title":"Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.","status":"RECRUITING","sponsor":"The Third Affiliated Hospital of Beijing University of Chinese Medicine","startDate":"2024-10-15","conditions":"Acupuncture, ADHD - Attention Deficit Disorder With Hyperactivity, Children","enrollment":76},{"nctId":"NCT02364817","phase":"","title":"ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2015-01","conditions":"Alcoholism, Attention Deficit Disorder With Hyperactivity","enrollment":113},{"nctId":"NCT07273695","phase":"","title":"Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders","status":"RECRUITING","sponsor":"IRCCS Eugenio Medea","startDate":"2025-09-19","conditions":"Emotional Dysregulation, Externalizing Problems, Oppositional Defiant","enrollment":80},{"nctId":"NCT07228650","phase":"","title":"ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes","status":"RECRUITING","sponsor":"King's College London","startDate":"2025-02-17","conditions":"Attention Deficit Hyerpactivity Disorder","enrollment":500},{"nctId":"NCT04501653","phase":"EARLY_PHASE1","title":"Precision Functional Brain Mapping in Psilocybin","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-06-01","conditions":"Psilocybin","enrollment":11},{"nctId":"NCT05916339","phase":"PHASE4","title":"AWARE: Management of ADHD in Autism Spectrum Disorder","status":"RECRUITING","sponsor":"Daniel Coury","startDate":"2023-10-01","conditions":"ADHD, Autism Spectrum Disorder","enrollment":500},{"nctId":"NCT01246765","phase":"","title":"National Pregnancy Registry for Psychiatric Medications","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2008-11","conditions":"Pregnant Women, Psychotropic Drugs","enrollment":5000},{"nctId":"NCT07169162","phase":"PHASE4","title":"ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder","status":"WITHDRAWN","sponsor":"Aytu BioPharma, Inc.","startDate":"2019-05","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":""},{"nctId":"NCT05469386","phase":"PHASE4","title":"Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom","status":"ACTIVE_NOT_RECRUITING","sponsor":"Florida International University","startDate":"2022-06-13","conditions":"ADHD","enrollment":288},{"nctId":"NCT06229600","phase":"","title":"REspiratory reHABilitation and PSYchiatric Comorbidities","status":"COMPLETED","sponsor":"Istituti Clinici Scientifici Maugeri SpA","startDate":"2024-01-02","conditions":"Respiratory Disease","enrollment":994},{"nctId":"NCT03511976","phase":"PHASE4","title":"Adaptive Response to Intervention (RTI) for Students With ADHD","status":"WITHDRAWN","sponsor":"Florida International University","startDate":"2018-05-14","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":""},{"nctId":"NCT07076576","phase":"NA","title":"Effects of Yoga in Children With Attention Deficit Hyperactivity Disorder","status":"COMPLETED","sponsor":"Pamukkale University","startDate":"2022-12-01","conditions":"Attention Deficit Disorder With Hyperactivity (ADHD), Yoga, Motor Skills","enrollment":34},{"nctId":"NCT06858527","phase":"NA","title":"Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04-01","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Substance-related Disorder","enrollment":132},{"nctId":"NCT04132557","phase":"","title":"A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2019-10-09","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":430000},{"nctId":"NCT06369714","phase":"NA","title":"Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.","status":"RECRUITING","sponsor":"Lei Lei, MD","startDate":"2023-02-24","conditions":"Attention Deficit Disorder With Hyperactivity, Executive Function Disorder","enrollment":210},{"nctId":"NCT05208255","phase":"NA","title":"Effect of Telerehabilitation-Based Exercise and Motor Imagery Training in Children With ADHD","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2022-08-15","conditions":"Adhd","enrollment":33},{"nctId":"NCT06910605","phase":"NA","title":"Exploring Parameters of Driving Simulation in Relation to Drug Holidays in ADHD Patients","status":"RECRUITING","sponsor":"Stefan Lakämper","startDate":"2025-06-02","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity, Driving Simulator Performance, ADHD","enrollment":26},{"nctId":"NCT05686772","phase":"","title":"Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis","status":"COMPLETED","sponsor":"Laval University","startDate":"2019-11-01","conditions":"Gambling Disorder, Psychotic Disorders","enrollment":520},{"nctId":"NCT06970418","phase":"","title":"Sleep Disorders, Chronotype, and Functional Impairment in the Restrictive ADHD Phenotype","status":"COMPLETED","sponsor":"Dr. Behcet Uz Children's Hospital","startDate":"2023-03-10","conditions":"Attention Deficit Disorder With Hyperactivity, Sleep Disorders, Circadian Rhythm, Quality of Life","enrollment":104},{"nctId":"NCT03638466","phase":"PHASE2","title":"Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD","status":"TERMINATED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2019-05-30","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Impulsive Aggression","enrollment":7},{"nctId":"NCT04113551","phase":"","title":"A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2019-10-01","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":17418},{"nctId":"NCT04082234","phase":"NA","title":"Reducing Disparities in Behavioral Health Treatment for Children in Primary Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2019-11-01","conditions":"ADHD","enrollment":300},{"nctId":"NCT06898008","phase":"","title":"Characterization of Children with Complaints of Excessive Daytime Sleepiness","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2024-01-01","conditions":"Excessive Daytime Sleepiness","enrollment":400},{"nctId":"NCT05133804","phase":"PHASE2","title":"Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD","status":"RECRUITING","sponsor":"University of Haifa","startDate":"2022-06-01","conditions":"Posttraumatic Stress Disorder","enrollment":53},{"nctId":"NCT04181736","phase":"PHASE4","title":"The BIomarker Guided (BIG) Study for Depression","status":"COMPLETED","sponsor":"Stanford University","startDate":"2022-09-14","conditions":"Major Depressive Disorder","enrollment":28},{"nctId":"NCT06828900","phase":"NA","title":"Empowering Caregivers in ADHD Treatment: Standard Care Vs. Decision Aid, Coaching, and AI Support","status":"ENROLLING_BY_INVITATION","sponsor":"Ariel University","startDate":"2024-11-19","conditions":"ADHD, ADHD, ADD, Shared Decision Making","enrollment":200},{"nctId":"NCT06797570","phase":"NA","title":"The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.","status":"NOT_YET_RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2025-01-25","conditions":"Attention Deficit Disorder, Attention Deficit Disorder (ADD), Attention Deficit Disorder with Hyperactivity","enrollment":130},{"nctId":"NCT06779825","phase":"","title":"Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-02","conditions":"ADHD","enrollment":30},{"nctId":"NCT06133231","phase":"NA","title":"Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2024-01-06","conditions":"Attention Deficit/Hyperactivity Disorder, Emotional Dysfunction, Irritable Mood","enrollment":30},{"nctId":"NCT04219280","phase":"PHASE4","title":"Evaluating Treatment of ADHD in Children with Down Syndrome","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-10-02","conditions":"Down Syndrome, ADHD","enrollment":100},{"nctId":"NCT06305078","phase":"NA","title":"Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-11-10","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":30},{"nctId":"NCT05301673","phase":"","title":"ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence","status":"ACTIVE_NOT_RECRUITING","sponsor":"King's College London","startDate":"2022-07-12","conditions":"Attention Deficit Hyperactivity Disorder, Cardiovascular Diseases, Medication Adherence","enrollment":600},{"nctId":"NCT04240756","phase":"PHASE3","title":"Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, College Park","startDate":"2020-08-06","conditions":"ADHD, Parenting","enrollment":240},{"nctId":"NCT05937347","phase":"NA","title":"Mindfulness and Cognitive Training Programs for Children with ADHD (the NeuroMind Study)","status":"COMPLETED","sponsor":"Fundació Sant Joan de Déu","startDate":"2023-07-20","conditions":"ADHD","enrollment":122},{"nctId":"NCT06050616","phase":"","title":"Multimodal Longitudinal and Predictive Modelling to Understand Eating Disorder Development","status":"COMPLETED","sponsor":"King's College London","startDate":"2023-11-15","conditions":"Binge-Eating Disorder, Anorexia Nervosa, Bulimia Nervosa","enrollment":23},{"nctId":"NCT04737512","phase":"EARLY_PHASE1","title":"Mindfulness-Based ADHD Treatment for Children: a Feasibility Study","status":"COMPLETED","sponsor":"Yale University","startDate":"2021-02-01","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":68},{"nctId":"NCT03904498","phase":"PHASE2","title":"COMT Inhibition Among Individuals With Comorbid AUD/ADHD","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2021-08-16","conditions":"Alcohol Use Disorder, Attention Deficit Hyperactivity Disorder","enrollment":62},{"nctId":"NCT06701500","phase":"","title":"Assessing Habitual, Goal-Directed, and Pavlovian Influences in Alcohol Use Disorder","status":"RECRUITING","sponsor":"Technische Universität Dresden","startDate":"2024-03-02","conditions":"Alcohol Use Disorder (AUD), Alcoholism, Substance Use Disorders","enrollment":180},{"nctId":"NCT06701487","phase":"","title":"Role of Pavlovian Mechanisms for Control Over Substance Use","status":"RECRUITING","sponsor":"Technische Universität Dresden","startDate":"2024-08-05","conditions":"Alcohol Use Disorder (AUD), Alcoholism, Substance Use Disorders","enrollment":200},{"nctId":"NCT04885166","phase":"NA","title":"Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention","status":"COMPLETED","sponsor":"Trinity College","startDate":"2021-05-04","conditions":"Prescription Drug Abuse (Not Dependent), Intentional Misuse","enrollment":249},{"nctId":"NCT05048186","phase":"","title":"Refining the Shared Decision Making Process Survey in ADHD Medication Decisions","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-02-24","conditions":"ADHD","enrollment":512},{"nctId":"NCT04481048","phase":"PHASE2","title":"Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-12-15","conditions":"Neurofibromatosis 1","enrollment":58},{"nctId":"NCT04519008","phase":"NA","title":"Effectiveness and Security Testing of a Mobile App","status":"NOT_YET_RECRUITING","sponsor":"Consorci Sanitari del Maresme","startDate":"2026-10-01","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":80},{"nctId":"NCT04991649","phase":"NA","title":"ACT for Parents of Children With Neurodevelopmental Comorbidities","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2021-04-11","conditions":"Asthma in Children, Attention Deficit Hyperactivity Disorder","enrollment":118},{"nctId":"NCT05351944","phase":"NA","title":"Dialectical Behavioral Therapy Skills for Impulsive Aggression","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-05-07","conditions":"Impulsive Aggression, ADHD, Executive Dysfunction","enrollment":66},{"nctId":"NCT04173000","phase":"NA","title":"Tools to Improve Medication Continuity in Adolescents With ADHD","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-07-02","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":16},{"nctId":"NCT03659929","phase":"PHASE3","title":"Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate","status":"COMPLETED","sponsor":"Arbor Pharmaceuticals, Inc.","startDate":"2018-09-18","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":320},{"nctId":"NCT06388694","phase":"NA","title":"Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2024-05-06","conditions":"Attention-deficit Hyperactivity","enrollment":315},{"nctId":"NCT04170738","phase":"PHASE4","title":"Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder","status":"COMPLETED","sponsor":"Jeffrey Newcorn","startDate":"2019-11-05","conditions":"Attention Deficit Disorder With Hyperactivity, Conduct Disorder, Substance Abuse","enrollment":33},{"nctId":"NCT00580814","phase":"NA","title":"Brain Dopamine Function in Adults With ADHD","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2006-02","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":75},{"nctId":"NCT01351272","phase":"PHASE3","title":"Genetic Modulation of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Wuerzburg University Hospital","startDate":"2011-05","conditions":"ADHD","enrollment":41},{"nctId":"NCT06235177","phase":"EARLY_PHASE1","title":"Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues","status":"NOT_YET_RECRUITING","sponsor":"The Essence of Integrative Health and Medicine Practice","startDate":"2024-10-10","conditions":"Schizoaffective Disorder, Bipolar Type, Bipolar Disorder, ADHD - Combined Type","enrollment":30},{"nctId":"NCT05202327","phase":"PHASE2","title":"PDC-1421 Treatment in Adult Patients With ADHD","status":"COMPLETED","sponsor":"BioLite, Inc.","startDate":"2022-04-07","conditions":"Attention-Deficit Hyperactivity Disorder (ADHD)","enrollment":70},{"nctId":"NCT05290311","phase":"","title":"Long-Term Effects of CBT on Quality of Life in Adults With ADHD","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2022-07-13","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":155},{"nctId":"NCT06170996","phase":"NA","title":"Internet-Based Behavioural Parent Training Intervention for Children With Attention Deficit/Hyperactivity Disorder","status":"COMPLETED","sponsor":"Wuhan Mental Health Centre","startDate":"2023-03-12","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":120},{"nctId":"NCT04823364","phase":"NA","title":"Evaluation of Brain Neurotransmitter Levels in Adults With ADHD, Before and After Stimulant Treatment","status":"TERMINATED","sponsor":"Weizmann Institute of Science","startDate":"2024-07-11","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":60},{"nctId":"NCT05651685","phase":"","title":"Treatment Recommendations for Patients With ADHD TDApp2","status":"COMPLETED","sponsor":"Universitat de Girona","startDate":"2022-12-12","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":32},{"nctId":"NCT03935646","phase":"PHASE2","title":"Acute Effects of Stimulant Medication in College Students With ADHD","status":"RECRUITING","sponsor":"University of Wyoming","startDate":"2020-02-11","conditions":"Attention Deficit Hyperactivity Disorder, Stimulant Use, Working Memory","enrollment":40},{"nctId":"NCT05551689","phase":"NA","title":"FOCUS ADHD Mobile Health App for Adult ADHD Patients","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2021-05-21","conditions":"ADHD","enrollment":73},{"nctId":"NCT02086864","phase":"PHASE2","title":"A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2014-03","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":151},{"nctId":"NCT02167048","phase":"PHASE1, PHASE2","title":"Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2014-06","conditions":"Attention Deficit Hyperactivity Disorders","enrollment":52},{"nctId":"NCT03136263","phase":"EARLY_PHASE1","title":"Oxytocin and Cognitive Control in Adult ADHD","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-12-14","conditions":"Attention Deficit/Hyperactivity Disorder","enrollment":24},{"nctId":"NCT06375525","phase":"NA","title":"Clinical Trial: The Efficacy of Janssen's Icon Application (App) in Improving Adherence to Treatment With Stimulant Medications in Children With Attention Deficit/Hyperactivity Disorder","status":"COMPLETED","sponsor":"Prof. Doron Gothelf MD","startDate":"2015-11","conditions":"Children Aged 6-18 Years With the Diagnosis of ADHD","enrollment":39},{"nctId":"NCT03936491","phase":"NA","title":"The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2019-08-01","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":105},{"nctId":"NCT06359899","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Ark Biopharmaceutical Co., Ltd.","startDate":"2024-05","conditions":"ADHD","enrollment":50},{"nctId":"NCT05754723","phase":"NA","title":"Using an Online Psychotherapy Program and AI-assisted Interventions for Postsecondary Student Mental Health","status":"WITHDRAWN","sponsor":"Dr. Nazanin Alavi","startDate":"2022-05-05","conditions":"Mental Health Issue","enrollment":""},{"nctId":"NCT04962334","phase":"NA","title":"Effect of Nutritional Formula Supplementation on Growth of Prepubertal Children Treated With Stimulants Medications for Attention Deficit Hyperactivity Disorder (ADHD)","status":"RECRUITING","sponsor":"Rabin Medical Center","startDate":"2021-07-01","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity","enrollment":70},{"nctId":"NCT05417607","phase":"NA","title":"A+ Treatment/Feasibility of Adapted ESDM-informed Caregiver Coaching Delivered Remotely for Children With ASD (Autism Spectrum Disorder) and ADHD (Attention Deficit Hyperactivity Disorder)","status":"COMPLETED","sponsor":"Duke University","startDate":"2020-12-16","conditions":"Autism Spectrum Disorder, Adhd","enrollment":57},{"nctId":"NCT02618434","phase":"PHASE3","title":"Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)","status":"COMPLETED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2016-02-16","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":297},{"nctId":"NCT03337646","phase":"PHASE4","title":"Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism","status":"COMPLETED","sponsor":"JPM van Stralen Medicine Professional","startDate":"2018-09-26","conditions":"Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder","enrollment":48},{"nctId":"NCT04386811","phase":"PHASE1","title":"Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.","status":"TERMINATED","sponsor":"Yale University","startDate":"2020-08-05","conditions":"ADHD","enrollment":3},{"nctId":"NCT06194162","phase":"NA","title":"Weighted Blankets for Sleep Disturbance Among Children With ADHD","status":"RECRUITING","sponsor":"University Hospital Bispebjerg and Frederiksberg","startDate":"2024-01-01","conditions":"Attention-deficit Hyperactivity, Attention Deficit Hyperactivity Disorder, Neurodevelopmental Disorders","enrollment":340},{"nctId":"NCT02618408","phase":"PHASE3","title":"Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)","status":"COMPLETED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2016-01-25","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":333},{"nctId":"NCT00318981","phase":"PHASE4","title":"Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD","status":"COMPLETED","sponsor":"University of Maryland, College Park","startDate":"2004-12","conditions":"Adult ADHD","enrollment":40},{"nctId":"NCT02293655","phase":"PHASE4","title":"The Effects of ADHD Medication (TEAM) Study","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2015-01-12","conditions":"ADHD","enrollment":204},{"nctId":"NCT01711021","phase":"PHASE2","title":"Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD","status":"COMPLETED","sponsor":"Noven Pharmaceuticals, Inc.","startDate":"2012-10","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":110},{"nctId":"NCT05517785","phase":"","title":"The Effect of Pharmacological Treatment for ADHD on Physical Performance in Male Adolescents","status":"UNKNOWN","sponsor":"Loewenstein Hospital","startDate":"2023-02-01","conditions":"ADHD","enrollment":70},{"nctId":"NCT04283604","phase":"PHASE4","title":"The Effects of a Single Dose of Methylphenidate on Motor Performance","status":"UNKNOWN","sponsor":"Loewenstein Hospital","startDate":"2021-05-27","conditions":"ADHD","enrollment":200},{"nctId":"NCT01778647","phase":"PHASE4","title":"Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD","status":"TERMINATED","sponsor":"Antonios Likourezos","startDate":"2009-12","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":15},{"nctId":"NCT03187353","phase":"PHASE4","title":"IMProving Executive Function Study","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2017-09-22","conditions":"Cognitive Impairment, RRSO","enrollment":69},{"nctId":"NCT02234557","phase":"NA","title":"Tai Chi Training for Children With ADHD","status":"COMPLETED","sponsor":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","startDate":"2014-07-17","conditions":"ADHD","enrollment":59},{"nctId":"NCT02136147","phase":"","title":"ADHD Medication and Predictors of Treatment Outcome","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2015-06","conditions":"Attention Deficit Disorder With Hyperactivity (ADHD)","enrollment":632}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":887,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Stimulant","Concerta","Ritalin","Focalin","Vyvanse"],"phase":"marketed","status":"active","brandName":"ADHD Medication","genericName":"ADHD Medication","companyName":"Massachusetts General Hospital","companyId":"massachusetts-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ADHD medications typically work by increasing the availability of neurotransmitters like dopamine and norepinephrine in the brain to improve attention and impulse control. Used for Attention-deficit/hyperactivity disorder (ADHD) in children and adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}